Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine, remifentanil, and dexmedetomidine in obstetric anesthesia
ChiCTR1800017125Phase 4Not yet recruiting
- Sponsor
- Tianjin Central Hospital of Obstetrics and Gynecology
- Start
- Jul 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ketamine, remifentanil and dexmedetomidine in labor anesthesia (3 arms), sponsored by Tianjin Central Hospital of Obstetrics and Gynecology. Primary endpoints: Catecholamine, Vital signs and 1 more. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
ketamineremifentanildexmedetomidine
03
Conditions
labor anesthesia
Beyond the preview
Go deeper on ChiCTR1800017125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017125.